Journal Article

Effects of early treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on the bronchoalveolar lavage proteome and oxylipids during bovine respiratory syncytial virus (BRSV) infection

Widgren, Anna, Baillif, Vincent, Timsit, Edouard, Guo, Yongzhi, Bergquist, Jonas, Yazdan Panah, Haleh, Hallbrink Ågren, Gabriella, Alvarez, Ignacio, Saias, Laure, Hägglund, Sara, Valarcher, Jean François, Dubourdeau, Marc, Hillström, Anna, Laloy, Eve

2024

Overview

Non-steroidal anti-inflammatory drugs (NSAID) are not recommended for use against pneumonia in humans, but are commonly utilised against bovine respiratory disease. This study aimed to determine if the use of NSAIDs in the early phase of bovine respiratory syncytial virus (BRSV)-infection limits pulmonary inflammation. Four to nine-week old calves were infected with BRSV by aerosol and were treated with either meloxicam intravenously on day (D)4 (n = 5, MEL), acetylsalicylat-DL-lysin intravenously on D4 and D5 (n = 5, ASA), or were left untreated as controls (n = 5, CTR). Clinical signs were monitored daily until necropsy on D7, BRSV-RNA was detected in nasal swabs and bronchoalveolar lavage (BAL) by RT-qPCR, inflammatory cells and proteins were identified in BAL by cytology and label-free quantitative mass spectrometry-based proteomics, respectively, and oxylipids were quantified in BAL and plasma by liquid chromatography tandem mass spectrometry with triple quadrupole mass detectors. The calves developed mild to moderate signs of respiratory disease and, with the exception of one MEL-treated and one ASA-treated calf, limited lung lesions. None of the treatments had a significant effect on virus replication, clinical signs or lung lesion extent. Relative to controls, both treatments initially induced a downregulation of proteins in BAL. Immunoglobulin (Ig)-related proteins, such as the Ig kappa and lambda locus and the joining chain of IgA and IgM, were downregulated in MEL-treated calves compared to controls. In addition, meloxicam induced an increased neutrophil influx in BAL in response to BRSV, possibly related to a reduction in plasma prostaglandin, and to a downregulation of The Liver X Receptor/ Retinoid X Receptor (LXR/RXR), the Farnesoid X Receptor (FXR)/RXR and the 24-Dehydrocholesterol Reductase (DHC24) signalling pathways in the lung. The risk of NSAIDs to increase neutrophil activity during stimulation with BRSV or other toll-like receptor 4 agonists needs to be investigated further. Since augmented neutrophil responses can be detrimental, the results of the present study do not support the use of NSAIDs to prevent the clinical expression of BRSV-infection.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Aerosols / Alveoli / Animals / Anti-inflammatory agents / Anti-Inflammatory Agents, Non-Steroidal - pharmacology / Anti-Inflammatory Agents, Non-Steroidal - therapeutic use / Antibiotics / Aspirin / Bacterial infections / Bronchoalveolar Lavage Fluid - chemistry / Bronchoalveolar Lavage Fluid - virology / Bronchus / Calves / Cattle / Cattle Diseases - drug therapy / Cattle Diseases - metabolism / Cattle Diseases - virology / Chromatography / Clinical Science / Cytology / Down-regulation / Histology / Immunoglobulin A / Immunoglobulin M / Infections / Inflammation / Klinisk vetenskap / Lavage / Lesions / Leukocytes (neutrophilic) / Liquid chromatography / Liver X receptors / Lung - drug effects / Lung - metabolism / Lung - pathology / Lung - virology / Lungs / Mass spectrometry / Mass spectroscopy / Meloxicam / Meloxicam - pharmacology / Meloxicam - therapeutic use / Necropsy / Neutrophils / Nonsteroidal anti-inflammatory drugs / Pathogens / Pneumonia / Proteins / Proteome / Proteomes / Proteomics / Quadrupoles / Reductases / Respiratory diseases / Respiratory syncytial virus / Respiratory Syncytial Virus Infections - drug therapy / Respiratory Syncytial Virus Infections - virology / Respiratory Syncytial Virus, Bovine / Retinoid X receptors / Ribonucleic acid / RNA / Signal transduction / TLR4 protein / Toll-like receptors / Viral infections / Viruses